Pipenzolate bromide: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 1: | Line 1: | ||
== Pipenzolate Bromide == | |||
[[File:Pipenzolate_bromide.svg|thumb|right|Chemical structure of Pipenzolate bromide]] | |||
'''Pipenzolate bromide''' is a [[muscarinic antagonist]] used primarily for its [[antispasmodic]] properties. It is a [[quaternary ammonium compound]] that acts by inhibiting the action of [[acetylcholine]] on [[muscarinic receptors]], thereby reducing [[smooth muscle]] contractions in the [[gastrointestinal tract]]. | |||
Pipenzolate bromide is used | |||
== | == Pharmacology == | ||
Pipenzolate bromide is classified as an [[anticholinergic]] agent. It works by blocking the [[muscarinic acetylcholine receptors]] (mAChRs), which are part of the [[parasympathetic nervous system]]. This blockade results in decreased [[gastrointestinal motility]] and [[secretion]], making it useful in the treatment of conditions such as [[irritable bowel syndrome]] and other [[spastic]] disorders of the gut. | |||
Pipenzolate bromide is | |||
== | === Mechanism of Action === | ||
The drug binds to the muscarinic receptors, preventing [[acetylcholine]] from exerting its effects. This leads to a reduction in the [[contraction]] of [[smooth muscle]] and a decrease in the production of [[gastric acid]] and other secretions. The primary therapeutic effect is the alleviation of [[spasms]] and pain associated with [[gastrointestinal disorders]]. | |||
* [[ | |||
== Clinical Uses == | |||
Pipenzolate bromide is used in the management of various [[gastrointestinal disorders]] characterized by excessive [[motility]] and [[spasms]]. These include: | |||
* [[Irritable bowel syndrome]] (IBS) | |||
* [[Peptic ulcer disease]] | * [[Peptic ulcer disease]] | ||
* [[ | * [[Gastroesophageal reflux disease]] (GERD) | ||
== Side Effects == | |||
As with other [[anticholinergic]] agents, pipenzolate bromide can cause a range of side effects due to its action on the [[parasympathetic nervous system]]. Common side effects include: | |||
* [[Dry mouth]] | |||
* [[Blurred vision]] | |||
* [[Constipation]] | |||
* [[Urinary retention]] | |||
In some cases, patients may experience [[tachycardia]] or [[confusion]], particularly in the elderly. | |||
== Contraindications == | |||
Pipenzolate bromide is contraindicated in patients with: | |||
[[Category: | * [[Glaucoma]] | ||
* [[Myasthenia gravis]] | |||
* Severe [[ulcerative colitis]] | |||
* [[Obstructive uropathy]] | |||
== Related Pages == | |||
* [[Anticholinergic]] | |||
* [[Muscarinic receptor]] | |||
* [[Gastrointestinal tract]] | |||
* [[Smooth muscle]] | |||
[[Category:Anticholinergic agents]] | |||
[[Category:Muscarinic antagonists]] | [[Category:Muscarinic antagonists]] | ||
[[Category: | [[Category:Quaternary ammonium compounds]] | ||
Latest revision as of 06:06, 16 February 2025
Pipenzolate Bromide[edit]

Pipenzolate bromide is a muscarinic antagonist used primarily for its antispasmodic properties. It is a quaternary ammonium compound that acts by inhibiting the action of acetylcholine on muscarinic receptors, thereby reducing smooth muscle contractions in the gastrointestinal tract.
Pharmacology[edit]
Pipenzolate bromide is classified as an anticholinergic agent. It works by blocking the muscarinic acetylcholine receptors (mAChRs), which are part of the parasympathetic nervous system. This blockade results in decreased gastrointestinal motility and secretion, making it useful in the treatment of conditions such as irritable bowel syndrome and other spastic disorders of the gut.
Mechanism of Action[edit]
The drug binds to the muscarinic receptors, preventing acetylcholine from exerting its effects. This leads to a reduction in the contraction of smooth muscle and a decrease in the production of gastric acid and other secretions. The primary therapeutic effect is the alleviation of spasms and pain associated with gastrointestinal disorders.
Clinical Uses[edit]
Pipenzolate bromide is used in the management of various gastrointestinal disorders characterized by excessive motility and spasms. These include:
Side Effects[edit]
As with other anticholinergic agents, pipenzolate bromide can cause a range of side effects due to its action on the parasympathetic nervous system. Common side effects include:
In some cases, patients may experience tachycardia or confusion, particularly in the elderly.
Contraindications[edit]
Pipenzolate bromide is contraindicated in patients with: